Warning Letter to BBCOS srl
Unspecified. See BBCOS's company page or this site's inspections.
On Nov 29, 2017, FDA's CDER sent BBCOS srl a warning letter citing stability.
- Letter date: Nov 29, 2017
- Issued by: CDER
- Closeout: —
The Letter
As posted on FDA.gov ↗; cited 21 CFR sections link to their page.FDA's site did not return the letter just now. Read it on FDA.gov ↗
Recent Letters Citing Stability
See them all- Guangdong Bangze Medicine Co., Ltd.Oct 26, 2026 · CDER · Stability, Quality unit
- Sanrace Biotechnology Co., Ltd.Oct 22, 2026 · CDER · Process validation, Stability
- TSP Solutions Pte. Ltd.Oct 22, 2026 · CDER · Stability, Supplier controls
- Silgan Dispensing SystemsOct 5, 2026 · CDER · Sterility assurance, Cleaning validation
- Hanlim Pharm Co., Ltd.Oct 2, 2026 · CDER · Aseptic processing, Sterility assurance
Record
- Recipient
- Mr. Raffaele Bertola
- FDA site ID (FEI)
- 3006447041
- Cited
Tags are assigned by Arca from the letter's text. A closeout letter means FDA found the firm's corrections adequate; no closeout does not mean the issues are unresolved. FDA warning letters